Compile Data Set for Download or QSAR
Report error Found 113 Enz. Inhib. hit(s) with all data for entry = 12841
TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732806BDBM732806(5-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732843BDBM732843(5-[5-carbamoyl-2-[(3S)-3- (morpholinomethyl)-3,4-d...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732827BDBM732827(N-(4-hydroxyphenyl)-N-[(3-methoxy-2- methyl-phenyl...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732805BDBM732805(5-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732841BDBM732841(N-[(2-cyanophenyl)methyl]-N-(4- hydroxyphenyl)-1,2...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732804BDBM732804(3-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732840BDBM732840(N-(4-hydroxyphenyl)-N-[(3-methoxy-2- methyl-phenyl...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732803BDBM732803(3-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732824BDBM732824(5-[4-chloro-5-(difluoromethyl)-2-[(3S)-3- (morphol...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732830BDBM732830(5-[5-fluoro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732807BDBM732807(5-[5-chloro-4-cyano-2-[(3S)-3- (morpholinomethyl)-...)
Affinity DataIC50: 5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732821BDBM732821(5-[5-chloro-4-(difluoromethoxy)-2-[(3S)-3- (morpho...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732833BDBM732833(5-[5-cyano-2-[(3S)-3-(morpholinomethyl)- 3,4-dihyd...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732851BDBM732851(5-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732812BDBM732812(5-[4-(difluoromethoxy)-5-fluoro-2-[(3S)-3- (morpho...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732832BDBM732832(5-[5-fluoro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732826BDBM732826(5-[5-acetamido-2-[(3S)-3- (morpholinomethyl)-3,4-d...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732818BDBM732818(5-[4-(difluoromethoxy)-2-[(3S)-3- (morpholinomethy...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732835BDBM732835(5-[5-cyano-2-[(3S)-3-(morpholinomethyl)- 3,4-dihyd...)
Affinity DataIC50: 7.5nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732844BDBM732844(N-(1H-indazol-5-yl)-N-[(3-methoxy-2- methyl-phenyl...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732813BDBM732813(5-[5-fluoro-4-methoxy-2-[(3S)-3- (morpholinomethyl...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732842BDBM732842(5-[4-carbamoyl-5-methoxy-2-[(3S)-3- (morpholinomet...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732849BDBM732849(5-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732831BDBM732831(N-[(2-cyanophenyl)methyl]-5-[4,5-difluoro- 2-[(3S)...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732848BDBM732848(5-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732817BDBM732817(5-[5-chloro-4-fluoro-2-[(3S)-3- (morpholinomethyl)...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732810BDBM732810(5-[5-chloro-4-methoxy-2-[(3S)-3- (morpholinomethyl...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732816BDBM732816(5-[5-chloro-4-fluoro-2-[(3S)-3- (morpholinomethyl)...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732802BDBM732802(3-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732829BDBM732829(5-[4,5-difluoro-2-[(3S)-3- (morpholinomethyl)-3,4-...)
Affinity DataIC50: 30nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732834BDBM732834(N-(4-chlorophenyl)-5-[4-cyano-5-methoxy- 2-[(3S)-3...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732852BDBM732852(5-[5-chloro-4-fluoro-2-[(3S)-3- (morpholinomethyl)...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732820BDBM732820(5-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732819BDBM732819(5-[5-chloro-4-(difluoromethoxy)-2-[(3S)-3- (morpho...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732811BDBM732811(N-(4-chlorophenyl)-5-[4- (difluoromethoxy)-2-[(3S)...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732825BDBM732825(N-(4-cyanophenyl)-5-[4-(difluoromethoxy)- 5-fluoro...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732839BDBM732839(N-(4-chlorophenyl)-5-[4-cyano-5-methoxy- 2-[(3S)-3...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732838BDBM732838(N-(4-chlorophenyl)-5-[4-cyano-5-methoxy- 2-[(3S)-3...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732823BDBM732823(5-[5-chloro-4-(difluoromethoxy)-2-[(3S)-3- (morpho...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732836BDBM732836(5-[4-cyano-5-methoxy-2-[(3S)-3- (morpholinomethyl)...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732822BDBM732822(5-[4-chloro-5-(difluoromethyl)-2-[(3S)-3- (morphol...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732801BDBM732801(3-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732814BDBM732814(5-[4-chloro-5-(difluoromethyl)-2-[(3S)-3- (morphol...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732828BDBM732828(5-[4-chloro-2-methyl-6-[(3S)-3- (morpholinomethyl)...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732847BDBM732847(N-(1H-indazol-6-yl)-N-[(3-methoxy-2- methyl-phenyl...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732846BDBM732846(N-[(2-cyanophenyl)methyl]-N-(1H-indazol- 6-yl)-1,2...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732815BDBM732815(N-(4-chlorophenyl)-5-[4- (difluoromethoxy)-5-fluor...)
Affinity DataIC50: 50nMAssay Description:BPS Bioscience, #50222: 3 ng of BCL-2, 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 L of 1:40 BCL-2 Peptide Ligand,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2 [G101V](Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732827BDBM732827(N-(4-hydroxyphenyl)-N-[(3-methoxy-2- methyl-phenyl...)
Affinity DataIC50: 100nMAssay Description:0.22 ng/μl of BCL-2 (SinoBiological, #10195-H08E1), 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 μL of 1:40 BCL-2 P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2 [G101V](Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732805BDBM732805(5-[5-chloro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 100nMAssay Description:0.22 ng/μl of BCL-2 (SinoBiological, #10195-H08E1), 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 μL of 1:40 BCL-2 P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2 [G101V](Human)
Eil Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 732832BDBM732832(5-[5-fluoro-2-[(3S)-3-(morpholinomethyl)- 3,4-dihy...)
Affinity DataIC50: 100nMAssay Description:0.22 ng/μl of BCL-2 (SinoBiological, #10195-H08E1), 5 μL of 1:100 anti-His Tb-labeled donor, 5 μL of 1:100 Dye-labeled acceptor, 5 μL of 1:40 BCL-2 P...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent

Displayed 1 to 50 (of 113 total ) | Next | Last >>
Jump to: